NG PRECISION+ product is part of the new generation of pregnancy tests launched by NG BIOTECH. This new product is dedicated to the OTC market with the objective to give access to women to lab quality results at home, with the gold standard sample. From a single drop of blood, NG PRECISION+ can be performed […]
From the 3rd to the 6th of July, NG Biotech participates at ESHRE, the European Society of Human Reproduction and Embryology, in Milan. The NG Biotech team will present the different blood pregnancy tests from the Women’s Health range. Do not hesitate to visit us on Booth G13 (Hall 4).
From the 23rd to the 26th of April, NG Biotech participates at ECCMID, the European Congress of Clinical Microbiology & Infectious Diseases, in Lisbon.
The perfect event to meet again face to face the NG Biotech team in Pavillon 2, Booth 1-29 and discuss potential R&D projects or products distribution.
From the 15th to the 18th of November, NG Biotech participates at the world forum for medicine, MEDICA 2021 in Messe Düsseldorf.
The NG Biotech team is looking forward to meet with you (Hall 3, Booth 3A46)
We are very honored to have welcomed Jean-Yves Le Drian, Minister of Europe and Foreign Affairs. He came to pay tribute to our strong capacity for innovation, our international development and to review the French government’s support under the Recovery Plan.
NG Biotech S.A.S. (NG) announced today the appointment of Fabio Baglioni as Chief Commercial Officer (CCO) to spearhead the next phase of the company’s ambitious growth strategy.
NG Biotech has obtained the Rapid Diagnostic Orientation Test (TROD) label for its NG-Test® IgG-IgM COVID-19 serological test following the ministerial decree of the 10th of July.
Visiting NG Biotech, the Minister of Higher Education, Research and Innovation announces the order for 1.5 million tests for the Directorate General of Health.
The Ministry of the Armed Forces supports and finances the Covid-19 screening test project carried by NG Biotech.